Dexmedetomidine or medetomidine for use in treating separation anxiety in dogs

The invention relates to dexmedetomidine, medetomidine or a pharmaceutically acceptable salt thereof for use in a method of treating separation anxiety in companion animals, particularly dogs, comprising administering to a subject in need thereof an effective amount of said compound as the active in...

Full description

Saved in:
Bibliographic Details
Main Authors Niinistö, Sauli, Ormio, Sanna, Sarén, Nina, Korpivaara, Mira
Format Patent
LanguageEnglish
Published 08.12.2022
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The invention relates to dexmedetomidine, medetomidine or a pharmaceutically acceptable salt thereof for use in a method of treating separation anxiety in companion animals, particularly dogs, comprising administering to a subject in need thereof an effective amount of said compound as the active ingredient. The active ingredient is preferably administered oromucosally, e.g. in the form of an oromucosal gel.
Bibliography:Application Number: AU20170378203